348 related articles for article (PubMed ID: 27610937)
1. Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.
Wang L; Panagiotoglou D; Min JE; DeBeck K; Milloy MJ; Kerr T; Hayashi K; Nosyk B
Drug Alcohol Depend; 2016 Nov; 168():22-29. PubMed ID: 27610937
[TBL] [Abstract][Full Text] [Related]
2. HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.
Beaulieu T; Hayashi K; Milloy MJ; Nosova E; DeBeck K; Montaner J; Kerr T; Ti L
J Acquir Immune Defic Syndr; 2018 May; 78(1):93-98. PubMed ID: 29630030
[TBL] [Abstract][Full Text] [Related]
3. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
[TBL] [Abstract][Full Text] [Related]
4. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
6. Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
Mazhnaya A; Meteliuk A; Barnard T; Zelenev A; Filippovych S; Altice FL
Int J Drug Policy; 2017 Sep; 47():187-195. PubMed ID: 28811159
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
Ozga JE; Syvertsen JL; Pollini RA
J Viral Hepat; 2022 Jul; 29(7):518-528. PubMed ID: 35357738
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
9. Inability to access primary care clinics among people who inject drugs in a Canadian health care setting.
Brar R; Milloy MJ; DeBeck K; Nosova E; Nolan S; Barrios R; Wood E; Hayashi K
Can Fam Physician; 2021 Dec; 67(12):e348-e354. PubMed ID: 34906953
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.
Childs E; Assoumou SA; Biello KB; Biancarelli DL; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Bazzi AR
Harm Reduct J; 2019 Feb; 16(1):14. PubMed ID: 30744628
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era.
Falade-Nwulia O; Gicquelais RE; Astemborski J; McCormick SD; Kirk G; Sulkowski M; Thomas DL; Mehta SH
Liver Int; 2020 Oct; 40(10):2407-2416. PubMed ID: 32770638
[TBL] [Abstract][Full Text] [Related]
12. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
13. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.
Falade-Nwulia O; Irvin R; Merkow A; Sulkowski M; Niculescu A; Olsen Y; Stoller K; Thomas DL; Latkin C; Mehta SH
J Subst Abuse Treat; 2019 May; 100():45-51. PubMed ID: 30898327
[TBL] [Abstract][Full Text] [Related]
14. Global policy and access to new hepatitis C therapies for people who inject drugs.
Doyle JS; Aspinall EJ; Hutchinson SJ; Quinn B; Gore C; Wiktor SZ; Hellard ME
Int J Drug Policy; 2015 Nov; 26(11):1064-71. PubMed ID: 26118794
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
[TBL] [Abstract][Full Text] [Related]
16. Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.
Prata Menezes NS; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
J Int AIDS Soc; 2024 Apr; 27(4):e26241. PubMed ID: 38632848
[TBL] [Abstract][Full Text] [Related]
17. Individual and network factors associated with HCV treatment uptake among people who inject drugs.
Falade-Nwulia O; Sacamano P; McCormick SD; Yang C; Kirk G; Thomas D; Sulkowski M; Latkin C; Mehta SH
Int J Drug Policy; 2020 Apr; 78():102714. PubMed ID: 32135398
[TBL] [Abstract][Full Text] [Related]
18. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
[TBL] [Abstract][Full Text] [Related]
19. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.
Artenie AA; Zang G; Daniel M; Fortier E; Jutras-Aswad D; Puzhko S; Bruneau J
Int J Drug Policy; 2017 Sep; 47():239-243. PubMed ID: 28587944
[TBL] [Abstract][Full Text] [Related]
20. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
Versfeld A; McBride A; Scheibe A; Spearman CW
Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
